Here we also observed that tumor cells displaying gal-3-binding sites increased their content of cell surface galectin-3 after cisplatin treatment and presented enhanced susceptibility to chemotherapeutic-induced cell death. This evidence concerns the gene LGALS3 and neoplasm.